Abstract:Transforming growth factor-β (TGF-β) family signaling controls diverse developmental processes and the pathogenesis of many diseases, including cancer and autoimmune and fibrotic diseases. TGF-β and related proteins signal through heteromeric serine-threonine kinase receptors at the cell surface and intracellular effectors called Smads. Advancement in the knowledge of Smads as key TGF-β signal transducers and transcription factors has made it possible to establish a comprehensive model for how the conceptually simple Smad signaling pathways control a broad range of cellular responses in response to a large family of TGF-β ligands (Derynck and Zhang 2003; Shi and Massague 2003; ten Dijke and Hill 2004; Feng and Derynck 2005). Smads orchestrate the transcription of specific gene networks through interactions with cooperating sequence-specific DNA-binding transcription factors, specific DNA response elements, and non-DNA-binding transcription coactivators or corepressors that act to modify local chromatin structure and/or engage the basal transcription machinery (Fig. 1) (for reviews, see Feng and Derynck 2005; Massague et al. 2005). Recent findings also suggest that the regulation of Smad activity through posttranslational modifications such as (de)phosphorylation, ubiquitylation, and sumoylation controls the magnitude and duration of TGF-β responses (Fig. 2) (for reviews, see Feng and Lin 2006; Schilling et al. 2006). This mechanism allows for specific yet robust gene activation or repression in response to TGF-β in a context-dependent manner. This chapter spotlights the properties of Smads as transcription factors. DNA-BINDING PROPERTIES OF SMADS Transcriptional activation is a highly regulated process requiring the rigorous interactions of DNA-binding transcription factors, coactivator proteins, and general transcription...

Physical and Functional Interaction Between GATA-3 and Smad3 Allows TGF-β Regulation of GATA Target Genes

Distinct Functions for the Transcription Factors GATA-3 and ThPOK During Intrathymic Differentiation of CD4+ T Cells

Axin and GSK3- Control Smad3 Protein Stability and Modulate TGF- Signaling.

Smad3 Differentially Regulates the Induction of Regulatory and Inflammatory T Cell Differentiation

Post-translational regulation of TGF-β receptor and Smad signaling.

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Human Smad3 and Smad4 Are Sequence-Specific Transcription Activators

Post‐translational Regulation of TGF‐β Receptor and Smad Signaling

Coordinate Regulation of TCR signaling, Notch, and Gata3 in T Cell Development (138.27)

Smad3 and Smad4 Cooperate with C-Jun/c-fos to Mediate TGF-β-induced Transcription

Posttranslational Regulation of Smads

Interaction of Smad3 and SRF-associated complex mediates TGF-beta1 signals to regulate SM22 transcription during myofibroblast differentiation.

Bcl11b, A Novel Gata3-Interacting Protein, Regulates T-Helper-2-Cell Differentiation and Function

TGF-β Signaling from Receptors to Smads

Signaling of Transforming Growth Factor‐β Family Members Through Smad Proteins

10 Transcriptional Control Via Smads

Analysis of the DNA-binding properties of TGF-β-activated Smad complexes unveils a possible molecular basis for cellular context-dependent signaling

Bcl11b, a Novel GATA3-interacting Protein, Suppresses Th1 While Limiting Th2 Cell Differentiation

STAT3 Selectively Interacts with Smad3 to Antagonize TGF-β

The mechanism of Smad2 and Smad3 in TGF-β1 signaling

Functional Characterization of Transforming Growth Factor Β Signaling in Smad2- and Smad3-deficient Fibroblasts*